| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 非免疫规划疫苗(元) | - | 1,051,603,657.29 | - | 1,308,081,995.46 |
| 技术服务费(元) | 9,884,717.75 | 2,817,057.49 | 201,208,839.13 | 8,474,043.79 |
| 免疫规划疫苗(元) | - | 42,854,287.42 | - | 58,455,589.45 |
| 中间产品(元) | 250,489,711.38 | 53,940,191.72 | 60,260,245.18 | 44,630,793.76 |
| 自主疫苗(元) | 2,152,143,841.01 | - | 2,542,114,326.59 | - |
| 营业成本(元) | ||||
| 非免疫规划疫苗(元) | - | 265,070,573.78 | - | 215,549,994.15 |
| 技术服务费(元) | 2,801,040.10 | 1,526,331.49 | 19,708,072.41 | 1,016,317.96 |
| 免疫规划疫苗(元) | - | 38,189,057.46 | - | 45,517,362.82 |
| 中间产品(元) | 95,883,177.95 | 35,184,913.84 | 24,202,442.01 | 9,837,316.57 |
| 自主疫苗(元) | 511,096,129.91 | - | 509,740,645.82 | - |
| 毛利(元) | ||||
| 非免疫规划疫苗(元) | - | 786,533,083.51 | - | 1,092,532,001.31 |
| 技术服务费(元) | 7,083,677.65 | 1,290,726.00 | 181,500,766.72 | 7,457,725.83 |
| 免疫规划疫苗(元) | - | 4,665,229.96 | - | 12,938,226.63 |
| 中间产品(元) | 154,606,533.43 | 18,755,277.88 | 36,057,803.17 | 34,793,477.19 |
| 自主疫苗(元) | 1,641,047,711.10 | - | 2,032,373,680.77 | - |
| 毛利率(%) | ||||
| 非免疫规划疫苗(%) | - | 74.79 | - | 83.52 |
| 技术服务费(%) | 71.66 | 45.82 | 90.21 | 88.01 |
| 免疫规划疫苗(%) | - | 10.89 | - | 22.13 |
| 中间产品(%) | 61.72 | 34.77 | 59.84 | 77.96 |
| 自主疫苗(%) | 76.25 | - | 79.95 | - |
| 收入构成(%) | ||||
| 非免疫规划疫苗(%) | - | 91.35 | - | 92.14 |
| 技术服务费(%) | 0.41 | 0.24 | 7.18 | 0.60 |
| 免疫规划疫苗(%) | - | 3.72 | - | 4.12 |
| 中间产品(%) | 10.38 | 4.69 | 2.15 | 3.14 |
| 自主疫苗(%) | 89.21 | - | 90.67 | - |
| 毛利构成(%) | ||||
| 非免疫规划疫苗(%) | - | 96.95 | - | 95.19 |
| 技术服务费(%) | 0.39 | 0.16 | 8.07 | 0.65 |
| 免疫规划疫苗(%) | - | 0.58 | - | 1.13 |
| 中间产品(%) | 8.58 | 2.31 | 1.60 | 3.03 |
| 自主疫苗(%) | 91.03 | - | 90.33 | - |